Multiple Myeloma Pricing, Reimbursement, and Access

June 13, 2019

Payers have become increasingly aware of the potential cost burden of multiple myeloma treatment over the past five years, due to several factors, The approvals of several high-cost biologics in increasingly early treatment lines, Increased patient life expectancies resulting in extended treatment durations, The surge in demand for high-cost combination regimens

Spotlight

Neuron UAE

Reliability, Loyalty and Expertise has been the core foundation upon which Neuron has established itself as one of the leading Third Party Administrators (TPAs) in the MENA region. Delivering unmatched services and business solutions, Neuron has carved a niche for itself as a TPA amongst regional and international insurance companies and several multi-national self-funded organizations. Moreover, our cordial relationship in the healthcare sector over a decade has extended our provider network, both in local and international grounds, providing immense sense of security to our members during travel.

Other Infographics
news image

What is Adoptive Cell Therapy?

Infographic | February 5, 2020

A type of immunotherapy in which T cells are given to a patient to help the body fight diseases. In cancer therapy, T cells are usually taken from the patient’s own blood or tumor tissue, grown in large numbers in the laboratory, and then given back to the patient to help the immune system fight the cancer.

Read More
news image

Cancer Drugs Bring in Most Pharma Revenue

Infographic | February 25, 2020

Worldwide cancer drug sales are already way ahead of those of other drugs and the revenue generated by them is expected to grow even larger by 2024. This is according to a report recently released by consultancy Evaluate, which analyses trends in the pharmaceutical sector. According to Evaluate's calculations, oncology drugs reached US$123.8 billion in sales in 2018, more than double that of the next item on the list, drugs treating diabetes with US$48.5 billion dollars in sales. By 2024, cancer drug sales are expected to almost double to US$236.6 billion dollars.

Read More
news image

Smart Pharmacovigilance

Infographic | May 23, 2021

Pharmacovigilance (PV) is essential to all life science organizations, ensuring that patients' health comes first. Various trends in global healthcare have transformed today’s PV function into a corporate asset that enhances brand value and contributes to new growth opportunities. However, existing safety systems impose a significant cost burden to operate.

Read More
news image

Latest Improvement on Pharmanews to Serve You Better

Infographic | April 16, 2020

Poised to give our readers and advertisers better services in spite of the COVID19 pandemic, Pharmanews–your global health journal has continued to improve on its services in terms of healthcare information dissemination, by keeping readers abreast of latest development in public health, especially on how to stay safe from the novel Coronavirus, as well as expanding our reach to over 250,000 readers per month.

Read More
news image

2021 global life sciences outlook

Infographic | August 24, 2021

The life sciences sector has played a pivotal role amid the COVID-19 pandemic. To cope with the global crisis, traditional competitors partnered to accelerate research and develop the fastest novel vaccine in the history. Governments, health systems, payers, retail pharmacies, and nonprofits are now working collaboratively with the sector to provide widespread distribution and administration.

Read More
news image

Pharma Technology Focus

Infographic | June 3, 2022

Pharma Technology Focus is free to read on all devices.

Read More

Spotlight

Neuron UAE

Reliability, Loyalty and Expertise has been the core foundation upon which Neuron has established itself as one of the leading Third Party Administrators (TPAs) in the MENA region. Delivering unmatched services and business solutions, Neuron has carved a niche for itself as a TPA amongst regional and international insurance companies and several multi-national self-funded organizations. Moreover, our cordial relationship in the healthcare sector over a decade has extended our provider network, both in local and international grounds, providing immense sense of security to our members during travel.

Events